Modern Slavery Statement
Last Updated: 16.11.2026
Introduction
This statement is made pursuant to Section 54 of the Modern Slavery Act 2015 and sets out the steps taken by LydiaRx Ltd ("LydiaRx" or "the Company") to prevent modern slavery and human trafficking in our business and supply chains.
About LydiaRx
LydiaRx is committed to conducting its business ethically and with integrity, and we are dedicated to upholding human rights across all aspects of our operations. We provide products and services to customers in the life sciences sector and maintain a responsible and transparent approach to our supply chain management.
Our Policies
- Supplier Code of Conduct: We have established a Supplier Code of Conduct that outlines our expectations regarding ethical conduct, labor practices, and human rights. We require all suppliers and contractors to adhere to these standards.
- Due Diligence Process: We conduct due diligence assessments of new and existing suppliers to evaluate their compliance with our Supplier Code of Conduct. This process includes risk assessments and periodic reviews to identify and mitigate potential risks of modern slavery and human trafficking.
- Employee Training: We provide training to our employees to raise awareness of modern slavery and human trafficking issues. This training includes identifying signs of exploitation, reporting procedures, and our commitment to ethical business practices.
- Whistleblowing Policy: We have established a whistleblowing policy that encourages employees, suppliers, and other stakeholders to report any concerns related to modern slavery or human trafficking. Reports are thoroughly investigated, and appropriate action is taken in response.
Supply Chain Management
We recognize the importance of understanding and addressing modern slavery risks within our supply chain. Our approach includes:
- Conducting risk assessments to identify high-risk suppliers and industries.
- Engaging with suppliers to promote awareness of modern slavery risks and expectations for compliance.
- Evaluating supplier performance based on ethical considerations, including labor practices and human rights.
- Taking appropriate action, including termination of contracts, in cases where suppliers fail to meet our ethical standards.
Future Steps
- Enhance our supplier engagement and due diligence processes to further mitigate risks.
- Expand our employee training programs to ensure all staff members understand their role in preventing modern slavery.
- Collaborate with industry partners and stakeholders to share best practices and promote ethical supply chain management.
Conclusion
LydiaRx remains committed to preventing modern slavery and human trafficking in all aspects of our business. We will continue to uphold the principles of transparency, accountability, and respect for human rights as we work towards a world free from exploitation and forced labor.
Signed: Najib Rehman, CEO Date: 16.11.2026